Epstein Secrets

e of the Director of National Intelligence, wrote to Ratcliffe criticizing him "over concerns about his recent handling of classified information." Slotkin asked Ratcliffe to testify about the issue, and "pointed out Mr. Ratcliffe seems to be politicizing intelligence for Mr. Trump's benefit, particular

llingness to license the patents after the pandemic. Regeneron, Eli Lilly Ask For FDA EUAs. NBC Nightly News ' (10/8, story 7, 2:15, Holt, 5.56M) Kristen Dahlgren reported that "on the same day the President touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments

ce of the Director of National Intelligence, wrote to Ratcliffe criticizing him "over concerns about his recent handling of classified information." Slotkin asked Ratcliffe to testify about the issue, and "pointed out Mr. Ratcliffe seems to be politicizing intelligence for Mr. Trump's benefit, particula

UAs. NBC Nightly News <https://playvideo.bulletinintelligence.com/b0b34baef0a747aba77ad73681a79838? pubid=fbi> ' (10/8, story 7, 2:15, Holt, 5.56M) Kristen Dahlgren reported that "on the same day the President touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments

e of the Director of National Intelligence, wrote to Ratcliffe criticizing him "over concerns about his recent handling of classified information." Slotkin asked Ratcliffe to testify about the issue, and "pointed out Mr. Ratcliffe seems to be politicizing intelligence for Mr. Trump's benefit, particular

llingness to license the patents after the pandemic. Regeneron, Eli Lilly Ask For FDA EUAs. NBC Nightly NewsVI' (10/8, story 7, 2:15, Holt, 5.56M) Kristen Dahlgren reported that "on the same day the President touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments

e of the Director of National Intelligence, wrote to Ratcliffe criticizing him "over concerns about his recent handling of classified information." Slotkin asked Ratcliffe to testify about the issue, and "pointed out Mr. Ratcliffe seems to be politicizing intelligence for Mr. Trump's benefit, particular

llingness to license the patents after the pandemic. Regeneron, Eli Lilly Ask For FDA EUAs. NBC Nightly NewsVI' (10/8, story 7, 2:15, Holt, 5.56M) Kristen Dahlgren reported that "on the same day the President touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments